Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-21-029356

CEO sold 7,850 shares at $20.33 ($159,591)

  • CEO acquired 15,625 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DAVIS STEPHEN CEO 2021-04-29 Option exercise +15,625 57,162 D
DAVIS STEPHEN CEO 2021-04-30 Sale −7,850 $20.33 $159,591 49,312 D
Derivatives
DAVIS STEPHEN CEO 2021-04-29 Option exercise · Restricted Stock Units −15,625 31,250 D
Open-market sales · 7,850 sh · avg $20.33 · $159,591
Loading xslF345X03/doc4.xml…